Loading…
ChronoScale Corporation is projected to rise to $19.49 by 2027, a +31% move from its current price of $14.84. CHRN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.18 | $14.84 | $15.54 | 0.00% |
| May 30 | $13.91 | $14.84 | $15.83 | +0.01% |
| May 31 | $13.71 | $14.84 | $16.07 | +0.01% |
| Jun 1 | $13.54 | $14.84 | $16.27 | +0.01% |
| Jun 2 | $13.40 | $14.84 | $16.44 | +0.02% |
| Jun 3 | $13.27 | $14.84 | $16.61 | +0.02% |
| Jun 4 | $13.15 | $14.84 | $16.76 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.15 | $14.84 | $16.76 | +0.02% |
| Week 2 | $12.51 | $14.85 | $17.62 | +0.04% |
| Week 3 | $12.04 | $14.85 | $18.32 | +0.06% |
| Week 4 | $11.66 | $14.85 | $18.93 | +0.08% |
| Week 5 | $11.33 | $14.86 | $19.48 | +0.11% |
| Week 6 | $11.04 | $14.86 | $20.00 | +0.13% |
| Week 7 | $10.78 | $14.86 | $20.48 | +0.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ChronoScale Corporation designs and develops a compute platform to support AI workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas.
ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
ChronoScale Corporation (CHRN) is a technology sector asset with a current price of $15.49 and a market capitalization of $2.22B. It ranks 1931 in the market, reflecting its size relative to peers.
The asset is described as a technology company that designs and develops AI compute platforms for large-scale deployments, operating as a subsidiary of Applied Digital Corporation. The current price aligns with the 2026 forecast, which shows a neutral sentiment for the year at an average of $15.49.
Looking further out, the forecast envisions a bullish path with substantial upside over the coming years, including 2027’s average climbing toward $21.17 and steadily rising through 2030 and beyond, reaching multi-year highs by 2040 and 2050 as indicated in the yearly averages.
A major floor 55.0% below — a decisive break under it would weaken the trend.
The nearest floor, 30.9% below — buyers have tended to step in here.
The nearest ceiling, 20.8% above — a clean break opens room to run.
A major ceiling 48.2% above — clearing it would confirm fresh momentum.
Key CHRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CHRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.43 | Sell | $15.33 | Sell |
| MA 10 | $16.03 | Sell | $15.35 | Sell |
| MA 20 | $14.68 | Buy | $14.61 | Buy |
| MA 50 | $12.07 | Buy | $12.81 | Buy |
| MA 100 | $10.91 | Buy | $11.03 | Buy |
| MA 200 | $7.77 | Buy | $9.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.00 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 7.43 | Neutral |
| Williams %R (14) | -84.62 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -4.69 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 15.38 | Buy |
| TRIX (15) | 1.54 | Buy |
| Awesome (5,34) | 2.49 | Buy |
| Ultimate (7,14,28) | 31.15 | Neutral |
| Momentum (10) | 0.56 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 15.00 | Sell |
| ADX (14) | 25.68 | Buy |
| ATR (14) | 0.58 | Info |
The 30-day technical picture is bullish overall, with RSI14 at 60 signaling constructive momentum.
SMA50 is $11.93 and SMA200 is $7.65, indicating upside potential as the price sits above shorter-term moving averages and approaches longer-term support levels.
Support is identified at $9.63 and resistance at $17.92, framing a traditional risk/reward setup. The 30-day range spans from $11.26 to $21.29, highlighting intermittent volatility within a bullish tilt.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.84 | $14.84 | $23.96 | 0% | Neutral | |
| $14.44 | $19.49 | $28.36 | +31% | Bullish | |
| $19.99 | $28.33 | $43.53 | +91% | Bullish | |
| $25.05 | $37.05 | $59.38 | +150% | Bullish | |
| $24.06 | $36.95 | $61.36 | +149% | Bullish | |
| $24.56 | $39.08 | $66.92 | +163% | Bullish | |
| $25.37 | $41.75 | $73.46 | +181% | Bullish | |
| $26.81 | $45.56 | $82.18 | +207% | Bullish | |
| $33.10 | $58.01 | $107.01 | +291% | Bullish | |
| $38.70 | $69.91 | $131.66 | +371% | Bullish | |
| $42.55 | $88.69 | $181.99 | +498% | Bullish | |
| $106.97 | $237.70 | $546.71 | +15.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.84 | $14.84 | $17.66 | +0.00% |
| June 2026 | $12.56 | $14.98 | $18.43 | +0.92% |
| July 2026 | $12.31 | $14.88 | $18.72 | -0.64% |
| August 2026 | $13.21 | $16.15 | $20.66 | +8.52% |
| September 2026 | $13.97 | $17.25 | $22.37 | +6.81% |
| October 2026 | $13.62 | $16.96 | $22.27 | -1.67% |
| November 2026 | $13.53 | $16.98 | $22.53 | +0.11% |
| December 2026 | $14.14 | $17.88 | $23.96 | +5.28% |
Click any year to see its month-by-month CHRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CHRN to range from $7.84 to $23.96 through 2026. The $14.84 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CHRN price prediction for 2027 points to an average of $19.49 (low $14.44, high $28.36) — a potential gain of +31% on today's $14.84. Buyers look set to stay in control over this stretch.
In 2028, CHRN is projected to trade between $19.99 and $43.53, averaging $28.33 — a potential gain of +91% from today's $14.84. That is up +45% on the projected 2027 average. Momentum favours further upside here.
ChronoScale Corporation's 2029 outlook centres on $37.05, within a $25.05 to $59.38 range. That is up +31% on the projected 2028 average. That marks a +150% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CHRN could reach as high as $61.36, with a base case around $36.95 and support toward $24.06 — roughly +149% from $14.84. Momentum favours further upside here.
Expect CHRN to range from $24.56 to $66.92 through 2031. The $39.08 average target implies a +163% move from current prices. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CHRN price prediction for 2032 points to an average of $41.75 (low $25.37, high $73.46) — a potential gain of +181% on today's $14.84. Momentum favours further upside here.
In 2033, CHRN is projected to trade between $26.81 and $82.18, averaging $45.56 — a potential gain of +207% from today's $14.84. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
ChronoScale Corporation's 2034 outlook centres on $58.01, within a $33.10 to $107.01 range. That is up +27% on the projected 2033 average. That marks a +291% change versus current levels. Momentum favours further upside here.
By 2035, CHRN could reach as high as $131.66, with a base case around $69.91 and support toward $38.70 — roughly +371% from $14.84. Buyers look set to stay in control over this stretch.
Expect CHRN to range from $42.55 to $181.99 through 2040. The $88.69 average target implies a +498% move from current prices. That is up +27% on the projected 2035 average. Momentum favours further upside here.
The CHRN price prediction for 2050 points to an average of $237.70 (low $106.97, high $546.71) — a potential gain of +15.0x on today's $14.84. Buyers look set to stay in control over this stretch.
Investing $1,000 in CHRN today (≈ 67.385445 CHRN) could be worth
$16,017.62
+$15,017.62 (+1502%) by 2050 · US Dollar
Based on the average projected CHRN price of $237.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CHRNwould be worth at today's price.
$1,000 invested in CHRN on May 27, 2025 (≈ 225.225222 CHRN) would be worth
$3,342.34
+$2,342.34 (+234.2%) today · 3.34× · US Dollar
Based on a CHRN entry price of $4.44 vs. today's $14.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.77 | $941.03 | -5.9% |
| 1 month ago | $11.37 | $1,305.19 | +30.5% |
| 3 months ago | $10.02 | $1,481.04 | +48.1% |
| 6 months ago | $4.73 | $3,137.42 | +213.7% |
| 1 year ago | $4.44 | $3,342.34 | +234.2% |
| All time (5.0y) ago | $82.65 | $179.55 | -82.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CHRN forecast.
Our base-case forecast reaches $30.00 around 2029.
Implied market cap at $30.00: $4.29B
The multi-year forecast shows a path of steady upside from a neutral starting point in 2026 to persistent bullish momentum thereafter. The 2026 forecast sits at an average of $15.49 with a 0% ROI and a neutral sentiment, anchoring the near term.
From 2027 onward, the outlook turns bullish with rising averages and meaningful upside. The 2027 average is $21.17 (ROI 36.7%), 2028 averages at $31.93 (ROI 106.2%), and 2029 at $41.97 (ROI 171%), illustrating accelerating upside.
By 2030, the average is $41.07 with a 165.2% ROI and a bullish sentiment, followed by continued gains through 2031–2033 and beyond. The forecast projects 2040 averaging $109.37 (ROI 606.3%) and 2050 averaging $293.86 (ROI 1797.7%), with a max reach as high as $229.84 in 2040 and $675.88 by 2050. These figures imply considerable upside but remain subject to market conditions and execution risk.
These are estimates, not guarantees, of future performance.
Overall, the longer-term view remains bullish, with steadily higher price levels and substantial upside by mid- to late century. The estimates present a trajectory of growth that could be sensitive to macro factors and company-specific developments.
Tap a question to reveal the answer.
2030 min $26.23, avg $41.07, max $69.35; ROI 165.2%; sentiment BULLISH.
The forecast shows a bullish path from 2027 onward with rising averages (2027 avg $21.17, 2028 $31.93, 2029 $41.97, 2030 $41.07) and high potential returns (e.g., 2040 avg $109.37, 2050 avg $293.86; ROI up to 1797.7%). However, 2026 is neutral with an average of $15.49 and 0% ROI, and these are estimates, not guarantees.
Yes. The 2040 forecast shows an average of $109.37 and a max of $229.84, indicating the possibility of surpassing $100 by 2040.
The 2050 forecast lists a max of $675.88, with an average of $293.86 and a min of $132.24.
Current price is $15.49 and market cap is $2.22B.
ChronoScale Corporation Community Discussion
0Share your ChronoScale Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.